A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo

Launched by BLUESKIN AS · Mar 13, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring how different factors might affect skin conditions like atopic dermatitis, alopecia areata, psoriasis, and vitiligo. Researchers want to understand how severe these conditions can get and how they change over time. They’ll also test a new way of checking skin lesions by asking participants to take pictures with their smartphones each week. The study will last for one year, during which about 370 adult patients, who have visible skin lesions and a smartphone, will share information about their symptoms and treatment to help track their condition.

To join the study, participants need to be over 18 and have been diagnosed with one of the four skin conditions. They should be ready to photograph their skin lesions weekly using their smartphone. Throughout the year, patients will provide updates about their skin and health, and researchers will also collect blood samples to look for new signs of disease activity. This study aims to learn more about these skin conditions and how technology can help monitor them effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult subjects \>18 years of age at screening.
• • Previous diagnosis by a physician of atopic dermatitis, psoriasis, vitiligo, or alopecia areata.
• • Visible lesions and willingness to photograph weekly using their smartphone
• • Availability of a smartphone
• Exclusion Criteria:
• • Has any physical attributes or skin conditions that in the opinion of the investigator might interfere with the evaluation of lesions (i.e., pigmentation, tattoos, extensive scarring, excessive hair growth or acne)
• • Has other clinically relevant illness that could interfere with healing of lesions (e.g. keloid scaring)
• • Current or previous malignant disease, including malignant melanoma and basal cell carcinoma, within 5 years
• • Some patients may have more than one of the four conditions. This is not an exclusion criterion per se but must be recorded.